J. L. McCoy

2.5k total citations
73 papers, 2.0k citations indexed

About

J. L. McCoy is a scholar working on Immunology, Oncology and Genetics. According to data from OpenAlex, J. L. McCoy has authored 73 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Immunology, 20 papers in Oncology and 18 papers in Genetics. Recurrent topics in J. L. McCoy's work include Immunotherapy and Immune Responses (22 papers), Macrophage Migration Inhibitory Factor (21 papers) and Virus-based gene therapy research (18 papers). J. L. McCoy is often cited by papers focused on Immunotherapy and Immune Responses (22 papers), Macrophage Migration Inhibitory Factor (21 papers) and Virus-based gene therapy research (18 papers). J. L. McCoy collaborates with scholars based in United States, Canada and Italy. J. L. McCoy's co-authors include J. P. Glynn, A Fefer, Ronald B. Herberman, J. H. Dean, Grace B. Cannon, R B Herberman, R. K. Oldham, Aldo Tagliabue, David Siwarski and Alexander Fefer and has published in prestigious journals such as The Journal of Immunology, JNCI Journal of the National Cancer Institute and Annals of the New York Academy of Sciences.

In The Last Decade

J. L. McCoy

72 papers receiving 1.7k citations

Peers

J. L. McCoy
David H. Lavrin United States
Myrthel E. Nunn United States
Arie C. Voordouw Netherlands
Marilyn L. Bach United States
Guy D. Bonnard United States
N. Stebbing United States
E W Lamon United States
Thelma B. Dunn United States
L P Svedersky United States
David H. Lavrin United States
J. L. McCoy
Citations per year, relative to J. L. McCoy J. L. McCoy (= 1×) peers David H. Lavrin

Countries citing papers authored by J. L. McCoy

Since Specialization
Citations

This map shows the geographic impact of J. L. McCoy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. L. McCoy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. L. McCoy more than expected).

Fields of papers citing papers by J. L. McCoy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. L. McCoy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. L. McCoy. The network helps show where J. L. McCoy may publish in the future.

Co-authorship network of co-authors of J. L. McCoy

This figure shows the co-authorship network connecting the top 25 collaborators of J. L. McCoy. A scholar is included among the top collaborators of J. L. McCoy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. L. McCoy. J. L. McCoy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McCoy, J. L., et al.. (2000). Cell-mediated immunity to tumor-associated antigens is a better predictor of survival in early stage breast cancer than stage, grade or lymph node status. Breast Cancer Research and Treatment. 60(3). 227–234. 46 indexed citations
2.
Bronaugh, Robert L., Colin Roberts, & J. L. McCoy. (1994). Dose-response relationship in skin sensitization. Food and Chemical Toxicology. 32(2). 113–117. 18 indexed citations
3.
Elliott, Robert L., Jonathan F. Head, & J. L. McCoy. (1994). Relationship of serum and tumor levels of iron and iron-binding proteins to lymphocyte immunity against tumor antigen in breast cancer patients. Breast Cancer Research and Treatment. 30(3). 305–309. 8 indexed citations
4.
Head, Jonathan F., Robert L. Elliott, & J. L. McCoy. (1993). Evaluation of lymphocyte immunity in breast cancer patients. Breast Cancer Research and Treatment. 26(1). 77–88. 45 indexed citations
5.
McCoy, J. L. & Ronald W. Conley. (1990). Surveying Board and Care Homes: Issues and Data Collection Problems. The Gerontologist. 30(2). 147–153. 10 indexed citations
6.
McCoy, J. L., et al.. (1981). Indirect leukocyte migration inhibition reactions to a 3-M KCl extract of lung adenocarcinoma by lung cancer patients.. PubMed. 66(2). 233–7. 2 indexed citations
7.
Siwarski, David, et al.. (1978). Conditions for generating and assaying human leukocyte inhibitory factor (LIF) induced by purified protein derivative (PPD). Immunopharmacology. 1(1). 57–69. 5 indexed citations
8.
Richardson, Ronald L., R. K. Oldham, Thomas C. Pomeroy, et al.. (1978). Immunologic monitoring and immunotherapy in Ewing's sarcoma. Cancer Immunology Immunotherapy. 4(2). 2 indexed citations
9.
Tagliabue, Aldo, J. L. McCoy, & Ronald B. Herberman. (1978). Refractoriness to Migration Inhibitory Factor of Macrophages of LPS Nonresponder Mouse Strains. The Journal of Immunology. 121(4). 1223–1226. 10 indexed citations
10.
Weese, James L., et al.. (1978). Brief communication: Technical modifications of the human agarose microdroplet leukocyte migration inhibition assay. Journal of Immunological Methods. 24(3-4). 363–370. 27 indexed citations
11.
Cannon, Grace B., J. L. McCoy, Robert Connor, et al.. (1978). Use of the Leukocyte Migration Inhibition Assay To Evaluate Antigenic Differences in Human Breast Cancers and Melanomas. JNCI Journal of the National Cancer Institute. 60(5). 969–978. 9 indexed citations
12.
Dean, J. H., et al.. (1977). Cellular immunity to SV40‐induced tumor cells and solubilized tumor‐associated antigens in immune mice using an isotopic footpad assay. International Journal of Cancer. 20(6). 951–959. 8 indexed citations
13.
McCoy, J. L., Lori Jerome, Grace B. Cannon, et al.. (1977). Leukocyte Migration Inhibition in Patients With Ewing's Sarcoma by 3- m Potassium Chloride Extracts of Fresh and Tissue-Cultured Ewing's Sarcomas 2. JNCI Journal of the National Cancer Institute. 59(4). 1119–1125. 10 indexed citations
14.
McCoy, J. L., et al.. (1977). Reactivity of Lung Cancer Patients in Leukocyte Migration Inhibition Assays to 3-M Potassium Chloride Extracts of Fresh Tumor and Tissue-Cultured Cells Derived From Lung Cancer2. JNCI Journal of the National Cancer Institute. 59(5). 1413–1418. 19 indexed citations
15.
McCoy, J. L., J. H. Dean, & Ronald B. Herberman. (1977). Human cell-mediated immunity to tuberculin as assayed by the agarose micro-droplet leukocyte migration inhibition technique: Comparison with the capillary tube assay. Journal of Immunological Methods. 15(4). 355–371. 42 indexed citations
16.
McCoy, J. L., M Padarathsingh, J. H. Dean, et al.. (1977). Migration Inhibition by an Agarose Microdroplet Assay: Monitoring of Tumor-Associated Antigens on a Simian Virus 40-Induced Sarcoma. The Journal of Immunology. 119(1). 306–310. 15 indexed citations
18.
Dean, J. H., et al.. (1975). Studies of lymphocyte stimulation by intact tumor‐cell and solubilized tumor antigen. International Journal of Cancer. 16(3). 465–475. 22 indexed citations
19.
Dean, J. H., et al.. (1975). Cellular immune reactivity in vitro and tumor rejection provided by tumor‐associated antigens of friend‐virus‐induced leukemia. International Journal of Cancer. 16(5). 701–712. 4 indexed citations
20.
Fefer, A, J. L. McCoy, & J. P. Glynn. (1967). Induction and regression of primary moloney sarcoma virus-induced tumors in mice.. PubMed. 27(9). 1626–31. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026